慢性肢体威胁性缺血一线血管内与外科血运重建策略的年龄依赖性结局
这项多中心回顾性队列研究纳入2013至2018年首次因慢性肢体威胁性缺血(CLTI)行血运重建的肢体,比较开放外科血运重建(OSR)与血管内血运重建治疗(ERT)后不同年龄组的死亡、并发症及无截肢生存,并计算标准化死亡比(SMR)。老年组(≥75岁)一年死亡率显著高于较年轻组,OSR后SMR为3.72、ERT后为4.04。
要点
- 年轻患者(<65岁)仅占CLTI人群的少数,OSR组22%、ERT组18%。
- ≥75岁患者一年死亡率显著高于<75岁患者,OSR与ERT两组趋势一致。
- 老年组死亡率约为一般人群预期值的3至4倍(OSR后SMR 3.72,ERT后SMR 4.04)。
核心结论
- 当前CLTI人群以老年患者为主,仅小部分小于65岁。
- 无论采用何种血运重建方式,年龄增长与显著更高的一年死亡率相关。
- 老年组死亡率约为一般人群预期值的3至4倍。
- 作者假设预防术后谵妄和纠正术前贫血的干预可能是有必要的,因为它们似乎是死亡的独立危险因素。
研究设计与样本
- 多中心回顾性队列研究,纳入2013至2018年首次因CLTI行血运重建的患者。
- 队列分为OSR和ERT两个治疗组,每组再按年龄分为<65岁(G1)、65-74岁(G2)、≥75岁(G3)三个亚组。
- 共274条肢体(43.9%)接受OSR,350条肢体(56.1%)接受ERT。
- 计算标准化死亡比(SMR),比较研究人群实际死亡与基于荷兰总人群年龄和性别别死亡率推算的预期死亡。
主要发现
- OSR组一年死亡率:G3 19.8% vs G2 7.1%和G1 6.7%,P=0.006。
- ERT组一年死亡率:G3 30.7% vs G2 12.7%和G1 7.8%,P=0.001。
- 老年组SMR:OSR后3.72,ERT后4.04。
- OSR后死亡的独立危险因素包括年龄(HR 1.03,95%CI 1.01-1.06,P=0.006)、术前血红蛋白水平(HR 0.79,95%CI 0.67-0.92,P=0.003)、组织丢失(HR 1.85,95%CI 1.22-2.79,P=0.004)、心脏病史(HR 1.56,95%CI 1.06-2.30,P=0.024)和术后谵妄(HR 2.75,95%CI 1.61-4.71,P<0.001)。
- ERT后死亡的独立危险因素包括年龄(HR 1.06,95%CI 1.04-1.08,P<0.001)、术前血红蛋白水平(HR 0.75,95%CI 0.65-0.87,P<0.001)、组织丢失(HR 1.71,95%CI 1.15-2.53,P=0.008)、慢性阻塞性肺疾病史(HR 1.99,95%CI 1.43-1.79,P<0.001)、脑血管意外史(HR 1.55,95%CI 1.09-2.21,P=0.015)、术后肺炎(HR 2.27,95%CI 1.24-4.16,P=0.008)、术后急性肾损伤(HR 2.42,95%CI 1.29-4.54,P=0.006)和术后脑血管意外(HR 8.17,95%CI 1.96-34.15,P=0.004)。
临床怎么用
- 作者假设预防术后谵妄和纠正术前贫血的干预可能是有必要的,因为它们似乎是死亡的独立危险因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic limb-threatening ischemia (CLTI) has a high mortality and amputation risk even after revascularization. Owing to an aging population the incidence of peripheral arterial disease is rising. However, the current age distribution in patients with CLTI and the impact of age on outcomes remains unclear. For this reason we performed an age-dependent analysis of mortality, morbidity, and amputation-free survival after open surgical revascularization (OSR) and endovascular revascularization therapy (ERT) with identification of risk factors for mortality. Standardized mortality ratios (SMR) were calculated, comparing observed deaths in the study population to expected deaths based on age and gender specific mortality rates of the overall Dutch population. METHODS: Patients revascularized for the first episode of CLTI between 2013 and 2018 were included in this multicenter retrospective cohort study. The cohort was divided into 2 treatment groups (OSR and ERT) who were each stratified in 3 age groups: early age group < 65 years (G1), middle age group 65-74 years (G2), and elderly age group ≥ 75 years (G3). RESULTS: During the study period 274 limbs (43.9%) were treated with OSR and 350 limbs (56.1%) with ERT. The young population (G1) is only a small part of the whole CLTI population, namely for OSR 22% and ERT 18%. The risk profile of the early age group was characterized by male gender and smoking, whereas the elderly age group was characterized by poor arterial runoff, tissue loss, hypertension, hypercholesterolemia, chronic kidney disease, history of heart disease, chronic obstructive pulmonary disease, and cerebrovascular disease. One year amputation rates were similar between the age groups. However, significantly higher one-year mortality rates were observed in patients ≥ 75 years in comparison to the low mortality rates in patients < 75 years (OSR: G3 19.8% vs. G2 7.1% and G1 6.7%, P = 0.006; ERT: G3 30.7% vs. G2 12.7% and G1 7.8%, P = 0.001). The SMR in this elderly group equaled 3.72 after OSR and 4.04 after ERT. Independent risk factors for mortality after OSR were age, hazard ratio (HR) 1.03 (95% confidence interval [CI] 1.01-1.06; P = 0.006), preoperative hemoglobin level (HR 0.79; 95% CI 0.67-0.92; P = 0.003), tissue loss (HR 1.85; 95% CI 1.22-2.79; P = 0.004), cardiac history (HR 1.56; 95% CI 1.06-2.30; P = 0.024), and development of postoperative delirium (HR 2.75; 95% CI 1.61-4.71; P < 0.001). After ERT we identified age, HR 1.06 (95% CI 1.04-1.08; P < 0.001); preoperative hemoglobin level, HR 0.75 (95% CI 0.65-0.87; P < 0.001); tissue loss, HR 1.71 (95% CI 1.15-2.53; P = 0.008); history of chronic obstructive pulmonary disease, HR 1.99 (95% CI 1.43-1.79; P < 0.001); history of cerebrovascular accident (CVA), HR 1.55 (95% CI 1.09-2.21; P = 0.015); the development of postoperative pneumonia, HR 2.27 (95% CI 1.24-4.16; P = 0.008); postoperative acute kidney injury (AKI), HR 2.42 (95% CI 1.29-4.54; P = 0.006); and postoperative CVA, HR 8.17 (95% CI 1.96-34.15; P = 0.004) as risk factors. CONCLUSIONS: The current CLTI population consists mostly of elderly patients and only a small part is younger than 65 years. This shift in the population is important because increasing age is associated with considerable higher one-year mortality rates regardless of the method of revascularization in patients with CLTI. The mortality rates in the elderly group are 3 to 4 times larger than expected in the general population. In relation to the high mortality of the elderly patient, we assume that interventions to prevent postoperative delirium and correct preoperative anemia may be warranted as they appear to be independent risk factors for mortality.
引用
- Smet N, Fourneau I, Roeleveld H, et al. Age-Dependent Outcome of First-Line Endovascular and Surgical Revascularization Strategies in Chronic Limb-Threatening Ischemia. Ann Vasc Surg. 2022. PMID: 35395378. doi:10.1016/j.avsg.2022.03.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。